Search Results

There are 18766 results for: content related to: Social, policy, and public health perspectives on new psychoactive substances

  1. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone)

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 454–463, Paul I. Dargan, Roumen Sedefov, Ana Gallegos and Dr David M. Wood

    Version of Record online : 13 JUL 2011, DOI: 10.1002/dta.312

  2. Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition

    British Journal of Pharmacology

    Volume 172, Issue 20, October 2015, Pages: 4970–4984, Andrés Ciudad-Roberts, Jorge Camarasa, Carlos J. Ciudad, David Pubill and Elena Escubedo

    Version of Record online : 9 OCT 2015, DOI: 10.1111/bph.13266

  3. Deaths of individuals aged 16–24 years in the UK after using mephedrone

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 225–232, Barbara Loi, John Martin Corkery, Hugh Claridge, Christine Goodair, Stefania Chiappini, Carla Gimeno Clemente and Fabrizio Schifano

    Version of Record online : 28 JUL 2015, DOI: 10.1002/hup.2423

  4. GHB and synthetic cathinones: clinical effects and potential consequences

    Drug Testing and Analysis

    Volume 3, Issue 9, September 2011, Pages: 552–559, Laurent Karila and Michel Reynaud

    Version of Record online : 2 DEC 2010, DOI: 10.1002/dta.210

  5. You have free access to this content
    The preclinical pharmacology of mephedrone; not just MDMA by another name

    British Journal of Pharmacology

    Volume 171, Issue 9, May 2014, Pages: 2251–2268, A R Green, M V King, S E Shortall and K C F Fone

    Version of Record online : 11 APR 2014, DOI: 10.1111/bph.12628

  6. You have free access to this content
    Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats

    British Journal of Pharmacology

    Volume 164, Issue 8, December 2011, Pages: 1949–1958, J Kehr, F Ichinose, S Yoshitake, M Goiny, T Sievertsson, F Nyberg and T Yoshitake

    Version of Record online : 21 NOV 2011, DOI: 10.1111/j.1476-5381.2011.01499.x

  7. Cathinone derivatives: A review of their chemistry, pharmacology and toxicology

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 439–453, John P. Kelly

    Version of Record online : 13 JUL 2011, DOI: 10.1002/dta.313

  8. You have free access to this content
    The new drug phenomenon

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 587–597, Simon D. Brandt, Leslie A. King and Michael Evans-Brown

    Version of Record online : 3 JUL 2014, DOI: 10.1002/dta.1686

  9. Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’

    Addiction

    Volume 107, Issue 4, April 2012, Pages: 792–800, Tom P. Freeman, Celia J. A. Morgan, James Vaughn-Jones, Nahida Hussain, Kash Karimi and H. Valerie Curran

    Version of Record online : 18 JAN 2012, DOI: 10.1111/j.1360-0443.2011.03719.x

  10. Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (Benzofury/ 6-APB) and NRG-2 with review of available evidence-based literature

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 4, July 2013, Pages: 356–364, Jeshoor Jebadurai, Fabrizio Schifano and Paolo Deluca

    Version of Record online : 23 JUL 2013, DOI: 10.1002/hup.2302

  11. Mephedrone, new kid for the chop?

    Addiction

    Volume 106, Issue 1, January 2011, Pages: 154–161, Adam R. Winstock, Luke R. Mitcheson, Paolo Deluca, Zoe Davey, Ornella Corazza and Fabrizio Schifano

    Version of Record online : 23 AUG 2010, DOI: 10.1111/j.1360-0443.2010.03130.x

  12. You have free access to this content
    A brief history of ‘new psychoactive substances’

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 401–403, L. A. King and A. T. Kicman

    Version of Record online : 20 JUL 2011, DOI: 10.1002/dta.319

  13. Contribution of serotonin and dopamine to changes in core body temperature and locomotor activity in rats following repeated administration of mephedrone

    Addiction Biology

    Sinead E. Shortall, Clare H. Spicer, Francis J. P. Ebling, A. Richard Green, Kevin C. F. Fone and Madeleine V. King

    Version of Record online : 16 JUL 2015, DOI: 10.1111/adb.12283

  14. Consumption of new psychoactive substances in a Spanish sample of research chemical users

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 4, July 2013, Pages: 332–340, Débora González, Mireia Ventura, Fernando Caudevilla, Marta Torrens and Magi Farre

    Version of Record online : 23 JUL 2013, DOI: 10.1002/hup.2323

  15. Aminoindanes—the next wave of ‘legal highs’?

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 479–482, P.D. Sainsbury, A.T. Kicman, R.P. Archer, L.A. King and R.A. Braithwaite

    Version of Record online : 11 JUL 2011, DOI: 10.1002/dta.318

  16. Substitutional potential of mephedrone: an analysis of the subjective effects

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 4, July 2013, Pages: 308–316, Máté Kapitány-Fövény, Máté Kertész, Adam Winstock, Paolo Deluca, Ornella Corazza, Judit Farkas, Gábor Zacher, Róbert Urbán and Zsolt Demetrovics

    Version of Record online : 23 JUL 2013, DOI: 10.1002/hup.2297

  17. You have free access to this content
    Mephedrone, Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) Induce Conditioned Place Preference in Mice

    Basic & Clinical Pharmacology & Toxicology

    Volume 115, Issue 5, November 2014, Pages: 411–416, Louise Karlsson, Mikael Andersson, Robert Kronstrand and Fredrik C. Kugelberg

    Version of Record online : 6 MAY 2014, DOI: 10.1111/bcpt.12253

  18. You have free access to this content
    Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age

    Addiction

    Volume 108, Issue 10, October 2013, Pages: 1700–1703, Paul Griffiths, Michael Evans-Brown and Roumen Sedefov

    Version of Record online : 19 JUL 2013, DOI: 10.1111/add.12287

  19. Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 233–243, Máté Kapitány-Fövény, Barbara Mervó, Máté Kertész, Ornella Corazza, Judit Farkas, Gyöngyi Kökönyei, Róbert Urbán and Zsolt Demetrovics

    Version of Record online : 28 JUL 2015, DOI: 10.1002/hup.2490

  20. You have free access to this content
    Mephedrone: use, subjective effects and health risks

    Addiction

    Volume 106, Issue 11, November 2011, Pages: 1991–1996, Adam Winstock, Luke Mitcheson, John Ramsey, Susannah Davies, Malgorzata Puchnarewicz and John Marsden

    Version of Record online : 27 JUL 2011, DOI: 10.1111/j.1360-0443.2011.03502.x